You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Partial remission

Showing 1 - 25 of 8,416
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
  • +2 more
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Center
Apr 4, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Acalabrutinib, Obinutuzumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Basking Ridge, New Jersey
  • +7 more
Nov 9, 2022

Diabetes, Type 2, Obesity Trial (OPTIFAST dietary supplement)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Obesity
  • OPTIFAST dietary supplement
  • (no location specified)
Feb 17, 2021

Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic

Withdrawn
  • CLL
  • +4 more
  • Treatment Free Observation
  • Basking Ridge, New Jersey
  • +8 more
Mar 4, 2022

Ulcerative Colitis, Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate Trial in Worldwide (Ulcerative colitis

Not yet recruiting
  • Ulcerative Colitis
  • +2 more
  • Ulcerative colitis Exclusion Diet
  • +3 more
  • Afula, Israel
  • +5 more
Mar 16, 2023

Crohn's Disease Trial in Worldwide (Modified Exclusive Enteral Nutrition, Crohn's Disease Exclusion Diet, Partial Enteral

Completed
  • Crohn's Disease
  • Modified Exclusive Enteral Nutrition
  • +3 more
  • Edmonton, Canada
  • +6 more
May 29, 2022

Diabetes Type 1 and Fitness.

Recruiting
  • Diabetes Mellitus
    • Poznan, Poland
      Department of Internal Medicine and Diabetiology Poznan Universi
    Jul 7, 2021

    Focal Segmental Glomerulosclerosis Trial in Dominican Republic, United States (Voclosporin)

    Terminated
    Has Results
    • Focal Segmental Glomerulosclerosis
    • Denver, Colorado
    • +22 more
    Aug 20, 2021

    Depression Trial (Neurofeedback sessions)

    Not yet recruiting
    • Depression
    • Neurofeedback sessions
    • (no location specified)
    Oct 19, 2023

    Breast Cancer Trial in Changchun, Shenyang (complete remission (CR) group, partial remission (PR) group, stable disease (SD)

    Completed
    • Breast Cancer
    • complete remission (CR) group
    • +3 more
    • Changchun, Jilin, China
    • +2 more
    Feb 19, 2020

    Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)

    Not yet recruiting
    • Proliferative Glomerulonephritis With Monoclonal IgG Deposits
    • Rochester, Minnesota
      Mayo Clinic Minnesota
    Dec 8, 2022

    Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • Garran, Australian Capital Territory, Australia
    • +12 more
    Nov 1, 2023

    Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • Methylprednisolone Injectable Suspension
    • +2 more
    • Nanjing, Jiangsu, China
      Jiong Zhang
    May 8, 2023

    Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

    Completed
    Has Results
    • Relapsed/Refractory Philadelphia Positive B-precursor ALL
    • Duarte, California
    • +21 more
    Sep 8, 2022

    Bullous Pemphigoid Trial (efgartigimod PH20 SC, Prednisone)

    Not yet recruiting
    • Bullous Pemphigoid
    • (no location specified)
    Dec 27, 2022

    Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • (no location specified)
    Jan 23, 2023

    Lung Cancer Stage III Trial (Almonertinib)

    Not yet recruiting
    • Lung Cancer Stage III
    • (no location specified)
    Aug 8, 2023

    Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (A combination of anti-PD-1

    Completed
    • Recurrent Cervical Carcinoma
    • +4 more
    • A combination of anti-PD-1 antibody camrelizumab and albumin-bound paclitaxel
    • Beijing, Beijing, China
      Lei Li
    Mar 12, 2022

    Primary Focal Segmental Glomerulosclerosis Trial in Rochester (Obinutuzumab)

    Recruiting
    • Primary Focal Segmental Glomerulosclerosis
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 13, 2021

    Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Discontinuation of maintenance treatment
    • Cork, Ireland
      Cork University Hospital
    May 10, 2023

    Prognostic Model of Rituximab in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Dec 28, 2022

    Prognostic Model of TAC in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Dec 28, 2022

    Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • glucocorticoid + tacrolimus
    • (no location specified)
    Dec 28, 2022

    Crohn Disease Trial (CDED+PEN+dairy products, PEN+usual care)

    Not yet recruiting
    • Crohn Disease
    • CDED+PEN+dairy products
    • PEN+usual care
    • (no location specified)
    Nov 2, 2022

    Prognostic Model of GC/CTX in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • glucocorticoid + cytoxan
    • (no location specified)
    Dec 28, 2022